{"id":137302,"date":"2024-10-24T09:38:49","date_gmt":"2024-10-24T04:08:49","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=137302"},"modified":"2024-10-24T09:38:53","modified_gmt":"2024-10-24T04:08:53","slug":"pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/","title":{"rendered":"Pharma stocks in which mutual funds increased their stake by 4% in Q2"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-221959861\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>India is the largest global supplier of generic drugs and the Indian pharmaceutical industry is growing rapidly, projected to reach $65 billion by 2024 and $130 billion by 2030. Growth is driven by increasing R&amp;D investments, government initiatives, and rising domestic healthcare demand.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1671542657\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>Mutual funds are important during market volatility because they offer diversification, reducing the risk of significant losses, and provide professional management to navigate fluctuating markets.&nbsp;<\/p><p>Additionally, mutual funds are cost-efficient compared to managing individual securities and follow disciplined investment approaches that help investors avoid emotional decisions during turbulent times.&nbsp;<\/p><p><strong>Listed below are some of the Pharmaceutical stocks in which Mutual Funds have increased their holding in Q2FY25, that you can add to your watchlist\u00a0<\/strong><\/p><div class=\"trade-content_5\" id=\"trade-3767468896\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/AMIORG\" target=\"_blank\" rel=\"noreferrer noopener\">Ami Organics<\/a><\/strong><\/h2><p>AMI Organics (AMI) is one of the leading research and development-driven manufacturers of specialty chemicals, focused on the development and manufacturing of advanced pharmaceutical intermediates for regulated and generic active pharmaceutical ingredients, New Chemical Entities, and key starting materials for agrochemical and fine chemicals.&nbsp;<\/p><p>With a market capitalization of Rs. 6,356.71 Crores, the shares of Ami Organics Limited were trading at Rs. 1552.90 per equity share, up 0.69 percent from the previous day\u2019s close price of Rs.1,542.20.&nbsp;<\/p><p>In Q2FY25 the Mutual Fund Corporations increased their holding in Ami Organics Limited from 8.61 percent in Q1FY25 to 13.07 percent in Q2FY25 by purchasing an additional 4.46 percent stake.&nbsp;<\/p><p>Its Revenue from operations grew by 14.93 percent from Rs. 154 Crores in Q1FY24 to Rs. 177 Crores in Q1FY25, accompanied by profits of Rs. 22 Crores to Rs. 15 Crores.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/ERIS\" target=\"_blank\" rel=\"noreferrer noopener\">Eris Lifesciences<\/a><\/strong><\/h2><p>Eris Lifesciences Limited is a leading player in the domestic branded formulations market engaged in the business of manufacture and marketing of pharmaceutical products.\u00a0<\/p><p>With a market capitalization of Rs. 17,424.26 Crores, the shares of Eris Lifesciences Limited were trading at Rs. 1,280.20 per equity share, up 0.26 percent from the previous day\u2019s close price of Rs. 1,276.85.&nbsp;<\/p><div class=\"trade-content-10\" id=\"trade-3802585316\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>In Q2FY25 the Mutual Fund Corporations increased their holding in Eris Lifesciences Limited from 14.52 percent in Q1FY25 to 17.03 percent in Q2FY25 by purchasing an additional 2.51 percent stake.&nbsp;<\/p><p>Its Revenue from operations grew by 55.55 percent from Rs. 460.03 Crores in Q1FY24 to Rs. 715.59 Crores in Q1FY25, accompanied by profits of Rs. 93.65 Crores to Rs. 89.42 Crores.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/GLAND\" target=\"_blank\" rel=\"noreferrer noopener\">Gland Pharma<\/a><\/strong><\/h2><p>Gland Pharma Limited is engaged in the business of pharmaceutical research, development, manufacturing, and marketing of complex injectables with a strong presence in injectables, oncology, and ophthalmology segments.&nbsp;<\/p><p>With a market capitalization of Rs.26,575.28 Crores, the shares of Gland Pharma Limited were trading at Rs. 1,612.20 per equity share, up 0.30 percent from the previous day\u2019s close price of Rs. 1,607.35.&nbsp;<\/p><p>In Q2FY25 the Mutual Fund Corporations increased their holding in Gland Pharma Limited from 30.53 percent in Q1FY25 to 32.83 percent in Q2FY25 by purchasing an additional 2.3 percent stake.&nbsp;<\/p><p>Its Revenue from operations grew by 15.97 percent from Rs. 1,209 Crores in Q1FY24 to Rs. 1,402 Crores in Q1FY25, accompanied by profits of Rs. 194 Crores to Rs. 144 Crores.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/PFIZER\">Pfize<\/a><\/strong><\/h2><p>With a market capitalization of Rs. 24,992.21 Crores, the shares of Pfizer Limited were trading at Rs. 5,471.80 per equity share, down 0.54 percent from the previous day\u2019s close price of Rs. 5,501.50.&nbsp;<\/p><p>In Q2FY25 the Mutual Fund Corporations increased their holding in Pfizer Limited from 8.32 percent in Q1FY25 to 10.43 percent in Q2FY25 by purchasing an additional 2.11 percent stake.&nbsp;<\/p><p>Its Revenue from operations grew by 5.93 percent from Rs. 531 Crores in Q1FY24 to Rs. 563 Crores in Q1FY25, accompanied by profits of Rs. 94 Crores to Rs. 151 Crores.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/GLENMARK\" target=\"_blank\" rel=\"noreferrer noopener\">Glenmark Lifesciences<\/a><\/strong><\/h2><p>With a market capitalization of Rs. 13,176.12 Crores, the shares of Glenmark Lifesciences Limited were trading at Rs. 1,075.40 per equity share, down 0.07 percent from the previous day\u2019s close price of Rs. 1,076.20.\u00a0<\/p><p>In Q2FY25 the Mutual Fund Corporations increased their holding in Glenmark Lifesciences Limited from 1.01 percent in Q1FY25 to 2.82 percent in Q2FY25 by purchasing an additional 1.81 percent stake.&nbsp;<\/p><p>Its Revenue from operations grew by 1.76 percent from Rs. 578.45 Crores in Q1FY24 to Rs. 588.62 Crores in Q1FY25, accompanied by profits of Rs. 135.45 Crores to Rs. 111.48Crores.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by: Bharath K.S<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading has-medium-font-size\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-1436931456\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>India is the largest global supplier of generic drugs and the Indian pharmaceutical industry is growing rapidly, projected to reach $65 billion by 2024 and $130 billion by 2030. Growth is driven by increasing R&amp;D investments, government initiatives, and rising domestic healthcare demand.&nbsp; Mutual funds are important during market volatility because they offer diversification, reducing [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":111747,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[1119,23922,4023,18607,23923,3047,948,936,2597],"class_list":["post-137302","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-ami-organics","tag-eris-lifesciences","tag-gland-pharma","tag-glenmark-lifesciences","tag-pfize","tag-pharma-stocks","tag-stock-market","tag-stock-market-news","tag-stocks-to-watch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stocks in which mutual funds increased their stake by 4% in Q2 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"India is the largest global supplier of generic drugs and the Indian pharmaceutical industry is growing rapidly, projected to reach $65 billion by 2024 and $130 billion by 2030.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stocks in which mutual funds increased their stake by 4% in Q2\" \/>\n<meta property=\"og:description\" content=\"India is the largest global supplier of generic drugs and the Indian pharmaceutical industry is growing rapidly, projected to reach $65 billion by 2024 and $130 billion by 2030.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-24T04:08:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-24T04:08:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/\",\"name\":\"Pharma stocks in which mutual funds increased their stake by 4% in Q2 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"datePublished\":\"2024-10-24T04:08:49+00:00\",\"dateModified\":\"2024-10-24T04:08:53+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"India is the largest global supplier of generic drugs and the Indian pharmaceutical industry is growing rapidly, projected to reach $65 billion by 2024 and $130 billion by 2030.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stocks in which mutual funds increased their stake by 4% in Q2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stocks in which mutual funds increased their stake by 4% in Q2 - Trade Brains Features","description":"India is the largest global supplier of generic drugs and the Indian pharmaceutical industry is growing rapidly, projected to reach $65 billion by 2024 and $130 billion by 2030.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stocks in which mutual funds increased their stake by 4% in Q2","og_description":"India is the largest global supplier of generic drugs and the Indian pharmaceutical industry is growing rapidly, projected to reach $65 billion by 2024 and $130 billion by 2030.","og_url":"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-10-24T04:08:49+00:00","article_modified_time":"2024-10-24T04:08:53+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/","url":"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/","name":"Pharma stocks in which mutual funds increased their stake by 4% in Q2 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","datePublished":"2024-10-24T04:08:49+00:00","dateModified":"2024-10-24T04:08:53+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"India is the largest global supplier of generic drugs and the Indian pharmaceutical industry is growing rapidly, projected to reach $65 billion by 2024 and $130 billion by 2030.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-in-which-mutual-funds-increased-their-stake-by-4-in-q2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stocks in which mutual funds increased their stake by 4% in Q2"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/137302","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=137302"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/137302\/revisions"}],"predecessor-version":[{"id":137303,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/137302\/revisions\/137303"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/111747"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=137302"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=137302"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=137302"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}